Oscar Health Inc. (NYSE:OSCR) saw an upside of 6.72% to $7.61 after adding $0.48 on Wednesday. The 5-day average trading volume is 1,666,953 shares of the company’s common stock. It has gained $8.56 in the past week and touched a new high 3 times within the past 5 days. An average of 1,464,933 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,880,343.
OSCR’s 1-month performance is -7.77% or -$0.08 on its low of $6.91 reached on 08/07/23. The company’s shares have touched a 52-week low of $2.05 and high of $9.89, with the stock’s rally to the 52-week high happening on 06/13/23. YTD, OSCR has achieved 209.32% or $5.13 and has reached a new high 34 times. However, the current price is down -23.06% from the 52-week high price.
Insider Transactions
OSCR stock investors last saw insider trading activity on Jun 06.Blackley Richard Scott (Chief Transformation Officer) most recently sold 23,955 shares at $8.39 per share on Jun 06. This transaction cost the insider $201,093. EVP, Chief Insurance Officer, Quane Alessandrea C., sold 11,859 shares at a price of $8.39 on Jun 06. Then, on Jun 02, Interim CFO Sankaran Sid sold 137,826 shares at a price of $7.15 per share. This transaction amounted to $985,456.
Valuation Metrics
OSCR stock has a beta of 1.04. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 0.37 while the price-to-book (PB) in the most recent quarter is 1.77, with the price to cash flow ratio at 8.14.
As well, the company’s long term debt to equity for the quarter ending June 29 was 0.32, while the total debt to equity was 0.32. The firm’s gross profit as reported stood at -$610.08 million against revenue of $3.96 billion.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income shrunk -88.96% to -$39.77 million, while revenue of -$226.05 million was -468.39% off the previous quarter. Analysts expected OSCR to announce -$0.23 per share in earnings in its latest quarter, but it posted -$0.07, representing a 69.60% surprise. EBITDA for the quarter stood at more than -$27.55 million. Shareholders hold equity totaling $218.35 million.
Let’s look briefly at Oscar Health Inc. (OSCR) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 08 August was 50.26% to suggest the stock is trending Neutral, with historical volatility in this time period at 49.99%.
The stock’s 5-day moving average is $7.28, reflecting a +2.64% or $0.19 change from its current price. OSCR is currently trading +0.33% above its 20-day SMA, +120.78% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +10.39% and SMA200 by+118.88%.
Stochastic %K and %D was 26.87% and 18.00% and the average true range (ATR) pointed at 0.49. The RSI (14) points at 47.79%, while the 14-day stochastic is at 41.52% with the period’s ATR at 0.46. The stock’s 9-day MACD Oscillator is pointing at -0.01 and -0.20 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Oscar Health Inc. (NYSE: OSCR), BofA Securities upgraded it to a Neutral rating. They previously had an Underperform rating on the stock. Analysts offering their rating for OSCR stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate OSCR as a “sell,”, while 5 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 2 have offered a “buy” rating.
What is OSCR’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $5.00 and a high of $12.00, with their median price target at $8.00. Looking at these predictions, the average price target given by analysts is for Oscar Health Inc. (OSCR) stock is $7.89.
